Timothy P Kelly is Chief Technology Officer of Caribou Biosciences, Inc.. Currently has a direct ownership of 37,500 shares of CRBU, which is worth approximately $41,625. The most recent transaction as insider was on Feb 20, 2025, when has been sold 37,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.5K
n/a 3M change
n/a 12M change
Total Value Held $41,625

Timothy P Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2025
BUY
Grant, award, or other acquisition
-
37,500 Added 50.0%
37,500 Common Stock

Also insider at

FIXX
Homology Medicines, Inc. Healthcare
TPK

Timothy P Kelly

Chief Technology Officer
Bedford, MA

Track Institutional and Insider Activities on CRBU

Follow Caribou Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBU shares.

Notify only if

Insider Trading

Get notified when an Caribou Biosciences, Inc. insider buys or sells CRBU shares.

Notify only if

News

Receive news related to Caribou Biosciences, Inc.

Track Activities on CRBU